glp 1 medications tirzepatide Understand GLP-1/GIP Dual Agonist and Its Effect on Current Weight Loss Therapy Tirzepatide GLP-1 Weight Loss Program

Discontinuing GLP-1 use before or early in pregnancy raises gestational weight gain, birth weight percentile, and the risk of pregnancy complications

And big questions remain, starting with: Will these meds improve your health in the long run, and if so, how

A healthy pregnancy in sickle cell disease is possible

Generation of L Cells in mouse and human small intestine organoids

Common Side Effects and Safety Considerations Gastrointestinal side effects are the most frequently reported adverse reactions with GLP-1 receptor agonists, affecting a substantial proportion of patients, particularly during treatment initiation

Importantly, only HC-fed Liv Fgf21/ mice were significantly resistant to liraglutide-induced weight loss (Figure 4C and D), suggesting that FGF21 contributes to the weight loss effects of liraglutide in mice maintained on low fat, high carbohydrate diets